Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
ConclusionsOur real-life data confirm the efficacy and tolerability of erenumab for the prevention of migraine in a difficult-to-treat population of patients with a high prevalence of chronic migraine and medication overuse.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
More News: Allergy & Immunology | Chronic Pain | Constipation | Genetics | Headache | Italy Health | Migraine | Neurology | Pain | Study